drugset / Trial / NCT02277782
Intrathecal Hydromorphone for Labor Analgesia
RandomizedSingle-groupQuadruple-blindPrevention
Summary
The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will: 1. Prolong the duration and improve the quality of analgesia in labor, and 2. Decrease the incidence of epidural-associated temperature increase in labor.
Timeline
- Start
- 2015-09-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydromorphone | Other / unclassified | 50 ug | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 1.7 mg | — |
| Background | Fentanyl | Other / unclassified | 17 ug | — |